With Type 1 Diabetes Delay Possible, Focus Now on Screening – Medscape
MedscapeUnivadisMedscapeUnivadisNo ResultsNo ResultsMiriam E. TuckerNovember 30, 2022The recent approval of teplizumab-mzwv (Tzield, Provention Bio) for the delay of type 1 diabetes by the US Food and Drug Administration is expected to advance…